Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	100724
Country	China

Received	2024-08-24 11:37
Peer-Review Started	2024-08-24 11:37
To Make the First Decision
Return for Revision	2024-10-20 11:05
Revised	2024-11-01 15:21
Second Decision	2024-12-04 02:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-04 07:48
Articles in Press	2024-12-04 07:48
Publication Fee Transferred	2024-11-10 10:49
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-12-17 07:21
Publish the Manuscript Online	2025-01-18 08:12

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Case Report
Article Title	Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Yun-Hao Luo, Ting He, Lu Lin, Rong-Qiu Wang, Hong-Xia Cai and Wen Hu
ORCID	Author(s) ORCID Number Wen Hu http://orcid.org/0009-0000-5587-8070
Funding Agency and Grant Number
Corresponding Author	Wen Hu, Department of Oncology, West China Tianfu Hospital, Sichuan University, No. 3966 South Second Section, Tianfu Avenue, Tianfu New District, Chengdu 610000, Sichuan Province, China. huwenzhongliu@163.com
Key Words	Advanced pancreatic cancer; Immunotherapy; Camrelizumab; Targeted therapy; Apatinib; Case report
Core Tip	Pancreatic cancer (PC) is among the most lethal malignancies worldwide, with minimal advancements in treatment over the past three decades. We report the case of a patient with highly malignant PC who demonstrated a poor response to chemotherapy. However, immunotherapy and targeted therapy extended the patient's progression-free survival and improved her quality of life. Immunotherapy and targeted therapy may offer new hope for PC patients.
Publish Date	2025-01-18 08:12
Citation	<p>Luo YH, He T, Lin L, Wang RQ, Cai HX, Hu W. Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report. <i>World J Gastrointest Oncol</i> 2025; 17(2): 100724</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i2/100724.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i2.100724

Full Article (PDF)	WJGO-17-100724-with-cover.pdf
CARE Checklist–2016	100724-CARE-Checklist-2016.pdf
Manuscript File	100724_Auto_Edited_014947.docx
Answering Reviewers	100724-answering-reviewers.pdf
Audio Core Tip	100724-audio.mp3
Conflict-of-Interest Disclosure Form	100724-conflict-of-interest-statement.pdf
Copyright License Agreement	100724-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	100724-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	100724-non-native-speakers.pdf
Peer-review Report	100724-peer-reviews.pdf
Scientific Misconduct Check	100724-scientific-misconduct-check.png
Scientific Editor Work List	100724-scientific-editor-work-list.pdf
CrossCheck Report	100724-crosscheck-report.pdf